Steady-state Pattern Electroretinogram Following Long Term Unilateral Administration of Timolol to Ocular Hypertensive Subjects

Overview

Journal Doc Ophthalmol

Specialty Ophthalmology

Date 1990 Sep 1

PMID 2276311

Citations 15

Authors

R Nesher

G L Trick

M A Kass

M O Gordon

Affiliations

Soon will be listed here.

Abstract

To determine whether long-term reduction of intraocular pressure leads to a corresponding preservation of the pattern electroretinogram (PERG), PERGs were studied in 21 patients with ocular hypertension who had received unilateral timolol therapy for a minimum of 6 years. The mean difference in intraocular pressure (IOP) between the placebo-treated and the timolol-treated eyes (over 6 years) was 2.4 mm Hg. Steady-state PERGs (16.0 rps) were obtained simultaneously in both eyes of each patient, with four check sizes (0.25, 0.5, 1.0 and 2.0 degrees). Significant (p less than 0.05) steady-state PERG deficits (i.e., amplitude more than two standard deviations below the mean value of age-matched controls) were observed in 16 eyes of 12 patients (10 placebo-treated and 6 timolol-treated eyes). The mean PERG amplitude did not differ significantly between the placebo-treated and timolol-treated eyes. However, a significant correlation (r = -0.423) in the IOP differences between the placebo-treated and timolol-treated eyes and the corresponding PERG amplitude differences was noted in three of the four test conditions (i.e. 0.25, 0.5, and 1.0 degrees). These results suggest that reducing IOP may preserve ganglion cell function in some patients with ocular hypertension.

Citing Articles

Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study.

Tirsi A, Gliagias V, Sheha H, Patel B, Moehringer J, Tsai J J Curr Glaucoma Pract. 2024; 17(4):178-190.

PMID: 38269268 PMC: 10803274. DOI: 10.5005/jp-journals-10078-1423.

Neural Conduction Along Postretinal Visual Pathways in Glaucoma.

Parisi V, Ziccardi L, Tanga L, Roberti G, Barbano L, Carnevale C Front Aging Neurosci. 2021; 13:697425.

PMID: 34408643 PMC: 8365149. DOI: 10.3389/fnagi.2021.697425.

XEN Gel Stent in the management of primary open-angle glaucoma.

Post M, Lubinski W, Sliwiak D, Podboraczynska-Jodko K, Mularczyk M Doc Ophthalmol. 2020; 141(1):65-76.

PMID: 32052260 PMC: 7347710. DOI: 10.1007/s10633-020-09753-4.

Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study.

Parisi V, Oddone F, Roberti G, Tanga L, Carnevale C, Ziccardi L Adv Ther. 2019; 36(4):987-996.

PMID: 30790180 DOI: 10.1007/s12325-019-0897-z.

A comparative study of structural, functional and circulatory parameters in glaucoma diagnostics.

Kurysheva N, Maslova E, Zolnikova I, Fomin A, Lagutin M PLoS One. 2018; 13(8):e0201599.

PMID: 30138396 PMC: 6107119. DOI: 10.1371/journal.pone.0201599.

References

Quigley H, Addicks E, Green W, MAUMENEE A . Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol. 1981; 99(4):635-49. DOI: 10.1001/archopht.1981.03930010635009. View

Marx M, Podos S, Bodis-Wollner I, Siegel M, Teitelbaum C, Maclin E . Flash and pattern electroretinograms in normal and laser-induced glaucomatous primate eyes. Invest Ophthalmol Vis Sci. 1986; 27(3):378-86. View

Dawson W, Trick G, Litzkow C . Improved electrode for electroretinography. Invest Ophthalmol Vis Sci. 1979; 18(9):988-91. View

RIGGS L, JOHNSON E, Schick A . Electrical Responses of the Human Eye to Moving Stimulus Patterns. Science. 1964; 144(3618):567. DOI: 10.1126/science.144.3618.567. View

Marx M, Podos S, Bodis-Wollner I, Lee P, Wang R, Severin C . Signs of early damage in glaucomatous monkey eyes: low spatial frequency losses in the pattern ERG and VEP. Exp Eye Res. 1988; 46(2):173-84. DOI: 10.1016/s0014-4835(88)80075-7. View

Epstein D, Krug Jr J, Hertzmark E, Remis L, Edelstein D . A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology. 1989; 96(10):1460-7. DOI: 10.1016/s0161-6420(89)32688-1. View

LAKOWSKI R, Bryett J, Drance S . A study of colour vision in ocular hypertensives. Can J Ophthalmol. 1972; 7(1):86-95. View

Sample P, Weinreb R, Boynton R . Acquired dyschromatopsia in glaucoma. Surv Ophthalmol. 1986; 31(1):54-64. DOI: 10.1016/0039-6257(86)90051-2. View

Trick G, Nesher R, Cooper D, Kolker A . Dissociation of visual deficits in ocular hypertension. Invest Ophthalmol Vis Sci. 1988; 29(10):1486-91. View

10.

Holder G . Significance of abnormal pattern electroretinography in anterior visual pathway dysfunction. Br J Ophthalmol. 1987; 71(3):166-71. PMC: 1041112. DOI: 10.1136/bjo.71.3.166. View

11.

Adams A, Rodic R, Husted R, Stamper R . Spectral sensitivity and color discrimination changes in glaucoma and glaucoma-suspect patients. Invest Ophthalmol Vis Sci. 1982; 23(4):516-24. View

12.

Berninger T, Arden G . The pattern electroretinogram. Eye (Lond). 1988; 2 Suppl:S257-83. DOI: 10.1038/eye.1988.149. View

13.

Trick G . PRRP abnormalities in glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 1986; 27(12):1730-6. View

14.

Kass M, Gordon M, Hoff M, Parkinson J, Kolker A, Hart Jr W . Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial. Arch Ophthalmol. 1989; 107(11):1590-8. DOI: 10.1001/archopht.1989.01070020668025. View

15.

Trick G . Retinal potentials in patients with primary open-angle glaucoma: physiological evidence for temporal frequency tuning deficits. Invest Ophthalmol Vis Sci. 1985; 26(12):1750-8. View

16.

Stamper R . Psychophysical changes in glaucoma. Surv Ophthalmol. 1989; 33 Suppl:309-18. View

17.

Harrison J, OConnor P, Young R, KINCAID M, Bentley R . The pattern ERG in man following surgical resection of the optic nerve. Invest Ophthalmol Vis Sci. 1987; 28(3):492-9. View

18.

Trick G, Cooper D, Kolker A, Nesher R . Pattern reversal electroretinogram (PRERG) abnormalities in ocular hypertension: correlation with glaucoma risk factors. Curr Eye Res. 1988; 7(2):201-6. DOI: 10.3109/02713688808995749. View

19.

WEINSTEIN G, Arden G, Hitchings R, Ryan S, Calthorpe C, Odom J . The pattern electroretinogram (PERG) in ocular hypertension and glaucoma. Arch Ophthalmol. 1988; 106(7):923-8. DOI: 10.1001/archopht.1988.01060140069027. View

20.

Kwitko G, Shin D, Ahn B, Hong Y . Bilateral effects of long-term monocular timolol therapy. Am J Ophthalmol. 1987; 104(6):591-4. DOI: 10.1016/0002-9394(87)90169-3. View